Project Grant K99NS146217
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $453,860 to Henry Ford Health + Michigan State University Health Sciences on June 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This project grant funds preclinical research investigating the metabolic regulation of neutrophil extracellular traps (NETs) in traumatic brain injury (TBI). The research will examine...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $196,588 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 1, 2025 through April 30, 2027. The award funds research to profile midbrain neuronal vulnerability in Parkinson's Disease, specifically investigating distinct RIT2 (Ras-related protein) neuronal...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Icahn School of Medicine at Mount Sinai a $629,796 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025 through July 31, 2030. This five-year award funds basic neuroscience research focused on computational mapping and quantification of cerebral metabolic pathways during brain development. The...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai received a $670,266 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on January 20, 2026, with a completion date of December 31, 2030. This research project, "Mapping the Epigenomic and Spatial Transcriptomic Landscape in Parkinson's Disease," will...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Maryland, Baltimore $654,218 on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This five-year project grant, extending through July 31, 2030, supports basic research investigating the mechanisms and intervention of cyclic GMP-AMP synthase (cGAS) signaling in traumatic brain injury (TBI)-induced...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant totaling $453,970 to the Hugo W. Moser Research Institute at Kennedy Krieger, Inc. under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award, effective June 1, 2025 through May 31, 2027, funds research investigating the therapeutic effects of intranasal heparin-binding epidermal growth factor (HB-EGF)...
- Federal Project Grant Award Summary The University of Pittsburgh received a $571,404 Project Grant awarded May 30, 2025, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The research project, titled "Adipokines as Novel Therapy to Promote Functional Recovery After Experimental Traumatic Brain Injury," will extend through April 30, 2030. This award funds...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $122,850 Project Grant on February 15, 2026, to the J. David Gladstone Institutes to support research on microglial control of thalamocortical circuits in Alzheimer's disease (AD). Under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), this two-year research initiative (through January 31, 2028) will investigate how the TREM2R47H genetic...
- Federal Grant Award Summary The Scripps Research Institute received a $145,588 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 15, 2025, with completion by January 31, 2029. This award supports fundamental research investigating the role of polyglutamate binding protein 1 (PQBP1) as a central regulator of inflammation in...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Van Andel Research Institute $123,163 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective June 1, 2025, with completion targeted for September 26, 2025. The project focuses on identifying cortical neuronal vulnerability and resilience in Parkinson's disease, specifically investigating which neurons are susceptible to misfolded...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded $126,735 to the Icahn School of Medicine at Mount Sinai on February 6, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This K99/R00 career development award supports Dr. Amelia Hicks's research into post-traumatic neurodegeneration (PTND) and the intersection of traumatic brain injury (TBI) and Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The award funds targeted training and early-stage research through January 31, 2028, enabling Dr. Hicks to develop expertise in TBI and PTND proteomics, biostatistical analysis, neuropathology, and post-mortem tissue analysis within Mount Sinai's Brain Injury Research Center. The research deliverables focus on identifying and validating pathological and multi-domain clinical signatures of PTND using blood-based proteomic data from the Atherosclerosis Risk in Community Study (ARIC). Through this work, Dr. Hicks will advance clinicopathological understanding of post-traumatic neurodegeneration, explore biological and environmental factors influencing risk and resilience, and develop personalized intervention approaches to improve long-term outcomes for TBI survivors. This research aligns with the National Plan to Address Alzheimer's Disease priority to advance cross-disciplinary investigation at the intersection of TBI and AD/ADRD.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $126.7k | 2/5/26 |